Skip to main content
Erschienen in: BMC Gastroenterology 1/2019

Open Access 01.12.2019 | Technical advance

A novel approach with holmium laser ablation for endoscopic management of intrahepatic biliary stricture

verfasst von: Jianying Lou, Qida Hu, Tao Ma, Wei Chen, Ji Wang, Prasoon Pankaj

Erschienen in: BMC Gastroenterology | Ausgabe 1/2019

Abstract

Background

Hepatolithiasis, featuring high incidence, severe symptoms, and common recurrence, poses a heavy disease burden. Endoscopic management provides an opportunity to cure hepatolithiasis, but fails to properly resolve biliary stricture without additional interventional techniques. An innovative approach towards endoscopic management of biliary stricture is required.

Methods

Holmium laser ablation was applied to biliary strictures via endoscopic access. Patients’ demographic, operative, and follow-up data after receiving holmium laser ablation were retrospectively collected for analysis.

Results

A total of 15 patients (4 males and 11 females) underwent stricture ablation by holmium laser via cholangioscopy. All the patients successfully received holmium laser ablation, indicating a technical success rate of 100%. No postoperative mortality or no major perioperative complication was observed. During the follow-up period, the recurrence-free rate was 73% at 2 years and 67% at 5 years.

Conclusions

We successfully developed a novel technique of biliary stricture removal by cholangioscopic holmium laser ablation with satisfying clinical outcomes.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
Ho:YAG
holmium:yttrium-aluminum-garnet
PTCS
percutaneous transhepatic cholangioscopy
s.d.
standard deviation

Background

Hepatolithiasis is a common biliary disorder found in Asian population, with an incidence rate ranging from 2 to 25% in Southeastern Asia [14]. Hepatolithiasis, characterized by intrabiliary stone formation, results in bile stasis, and sometimes recurrent cholangitis. Patients suffering from the disease also bear high risk of stone recurrence even after surgical treatment, mainly due to unsolved etiological problems such as anatomical biliary stricture or transient portal bacteremia [5, 6]. Additionally, hepatolithiasis is also an established risk factor for cholangiocarcinoma with very poor prognosis [4]. Therefore, the high incidence, the severe symptoms, and the common recurrence altogether contribute to a heavy disease burden on the society and a low quality of life for the patients.
Current principles for hepatolithiasis management include stone clearance, biliary stricture removal, proper bile drainage, and resection of severely involved liver, aiming to reduce the postoperative recurrence rate [7]. A variety of methods have been practiced for clinical hepatolithiasis management. One major approach is hepatic resection, which simultaneously resolves the problems of intrahepatic stones and biliary stricture by en-bloc surgical removal [8, 9]. Hepatic resection could also benefit the patients with reduced risks of cholangiocarcinoma [10], because the technique allows for complete removal of the liver parenchyma with the potential of carcinogenesis. Another approach is endoscopic removal of intrahepatic stone, featured by minimally invasive lithotomy that significantly enhances postoperative recovery and reduces hospital stay [11, 12]. The endoscopic lithotomy procedure could be achieved by either choledochoscopy via an exploratory incision into the common bile duct or cholangioscopy via percutaneous transhepatic approach [6, 1114]. In particular, the patients with recurrent hepatolithiasis, who might have complicated surgical history or insufficient liver remnant, are usually unable to tolerate another major hepatic resection due to severe adhesion or possible postoperative liver function failure. Endoscopic approach proposes an opportunity to cure hepatolithiasis for those “inoperable” patients, but cannot properly resolve biliary stricture without additional interventional techniques.
Currently, only a few methods are available for biliary stricture management, including biliary stent [15, 16], balloon dilation [17, 18], radiofrequency ablation [19], and biliary scraper [20]. However, the recurrent rate of hepatolithiasis remains high. Effective management strategy in endoscopic approach for biliary stricture is still required. Here we propose an innovative approach using a holmium:yttrium-aluminum-garnet (Ho:YAG) surgical laser, a widely used technique in lithotripsy, for stricture ablation and complete stone clearance in endoscopic lithotomy.

Methods

Operative procedures

An endoscope with a 7.5 F outer diameter and a 3.6 F functioning route (Olympus, Japan) was applied for percutaneous cholangioscopy via a T-tube tract or other available access to the biliary tree. Continuous warm 0.9% saline solution (34–38 °C) was flushed via the functioning route for proper distension of the biliary ducts and clear vision of the surgical field after debris elimination. In situation of an encountered biliary stricture, a 200 mm optical fiber was inserted into the functioning route to access the stricture site, with the other end connected to a 60 W solid-state holmium unit consisted of a VersaPulse PowerSuite holmium laser (Lumenis, Yokneam, Isreal) and a control module (ZTC, Xiamen, China). The laser beam frequency was set to 6–10 Hz, and the energy was set to 0.5–1.0 J.
We initiated stricture ablation using the Ho:YAG laser at the superficial inner surface of the biliary stricture, and carefully cut the stricture in a spiral manner within the depth of 1 mm (Fig. 1). The horizontal or transverse cutting, other than the spiral cutting, could eventually damage the adjacent vascular structure, which could lead to catastrophic consequences such as massive bleeding and should therefore be avoided. Mild biliary bleeding could be well controlled by holmium laser cautery using same beam energy and frequency as laser cutting. Active biliary bleeding should be managed with laser cautery at first, or be managed with prepared open hepatectomy to remove the bleeding lesions if unsuccessful with laser cautery. In most circumstances of stricture removal, the biliary stricture would loosen to let through cholangioscopy, after cutting the biliary stricture on less than 1/4 spiral of the inner surface. The reason might be that lysis of the fibrosis adhesion in part of the stricture tissue subsequently resulted in spontaneous lysis of the whole stricture. The cholangioscopy was then able to access the obstructed segment of the liver to continue the lithotripsy. The holmium laser ablation could be repeatedly applied to further biliary stricture until the biliary tree was free of stricture.

Study design

We retrospectively reviewed the patients who underwent Ho:YAG laser stricture ablation from May 2012 to June 2015 at the Department of Hepatobiliary and Pancreatic Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine. All the medical records from the electronic medical record system and the archived documents were used to collect demographic, operative, and follow-up data. Patients’ age, gender, stricture condition, procedure duration, and status of biliary stones were collected as variables of interests. Subsequent medical records after stricture ablation were analyzed to determine clinical success, follow-up duration, occurrence of stricture or stone recurrent. The patients were evaluated with ultrasound sonography after stone clearance. This study was approved by the institutional review board (approval number 2012–355). All the patients signed the informed consent before the procedure.

Statistical analysis

Data are presented as mean ± standard deviation (s.d.). Analysis of variance or the nonparametric Kruskal-Wallis test was used to compare continuous factors, and the Pearson χ2 test was used for categorical variables. Recurrence-free survival analysis was performed to ascertain mean duration from stone clearance to recurrence, with Kaplan-Meier plots constructed. Statistical analyses were performed by Prism 7 (GraphPad, La Jolla, USA).

Results

A total of 15 patients (4 males and 11 females) underwent stricture ablation by Ho:YAG laser via cholangioscopy (Table 1). Among them, 12 patients were referred from the local medical centers, and the other 3 patients were directly admitted to our center. The average age of the patients was 58 ± 9 years old (mean ± s.d.; median 58, range 41–70). All patients had biliary stricture with multiple intrahepatic stones. These patients were initially diagnosed as biliary stones at 47 ± 14 years old (mean ± s.d.; median 52, range 23–64), and progressed to biliary stricture requiring operation in 11 ± 8 years (mean ± s.d.; median 10, range 1–30).
Table 1
Demographic characteristics of included patients
Case #
Gender
Age (years old)
Age of initial hepatolithiasis diagnosis (years old)
Previous surgical history
1
Male
63
43
None
2
Female
70
60
(1) Open cholecystectomy (2) open common bile duct exploration (CBDE)
3
Female
53
23
(1) Open cholecystectomy & CBDE (2) open left lateral hepatectomy & CBDE
4
Male
65
60
(1) Open cholecystectomy & CBDE (2) open left hemihepatectomy & CBDE
5
Male
58
52
(1) Open cholecystectomy & CBDE (2) ERCP with stone removal
6
Female
66
64
Open cholecystectomy & CBDE
7
Female
68
58
(1) Open cholecystectomy (2) open CBDE
8
Female
56
41
(1) Open cholecystectomy (2) open CBDE
9
Female
65
52
(1) Open cholecystectomy (2) open CBDE
10
Female
67
61
Open cholecystectomy
11
Female
41
31
Open cholecystectomy & CBDE
12
Female
58
38
(1) Open cholecystectomy (2) open CBDE
13
Male
48
38
Open cholecystectomy, CBDE, left lateral hepatectomy & hepaticojejunostomy
14
Female
41
26
(1) Open cholecystectomy (2) open CBDE
15
Female
58
57
None
ERCP endoscopic retrograde cholangiopancreatography
The diagnosis of intrahepatic biliary stricture in all patients was confirmed during the operation. The 15 cases were all presented with multiple pigment stones, among which 5 cases (33%) had choledocal stones (Table 2). All the cases presented single biliary stricture, with 7 cases in the left lobe, 7 cases in the right lobe mainly in segments VI and VII, and 1 case in the confluent biliary duct. All the patients successfully received Ho:YAG laser ablation of biliary stricture via choledocoscopy or cholangioscopy via routes of previously placed T tube (10 cases), open operation (4 cases), or laparoscopic access (1 case), with a technical success rate of 100%. The total operation time for the initial cholangioscopy with stricture ablation was 47 ± 12 min (mean ± s.d.; range 25–65). Specifically, the Ho:YAG ablation procedure took the surgeons only 25 ± 11 s (mean ± s.d.; range 12–44) to open the stricture. The residual stones were then eliminated by subsequent cholangioscopic lithotripsy or stone removal procedures with a median time of 2 sessions (range was no postoperative mortality or major perioperative complication such as biliary hemorrhage or liver failure. Minor discomforts in patients were observed: one patient developed abdominal distension with temporary fever due to incomplete ileus; one patient had fever with the maximum body temperature of 38.3 °C; another patient had diarrhea 3 days post the procedure. These three patients were well managed with conservative treatment and finally discharged.
Table 2
Characteristics of biliary stricture and perioperative parameters
Case #
Location of the biliary stricture
Location of hepatolithiasis
Access route of the cholangioscopic stricture ablation
Duration of the initial cholangioscopy (mins)
Operative duration of Ho:YAG laser ablation (secs)
Subsequent cholangioscopy sessions
Major postoperative complications
1
Sgts II-III
Bilateral lobes & CBD
Laparoscopic
45
12
4
No
2
Sgts II-III
Bilateral lobes
T tube
60
20
4
No
3
Sgts VI-VII
Bilateral lobes & CBD
T tube
50
32
0
No
4
Right hepatic duct
Right lobe & CBD
T tube
55
12
3
No
5
Sgts II-III
Bilateral lobes
T tube
50
12
3
No
6
Left hepatic duct
Left lobe
T tube
50
34
2
No
7
Left hepatic duct
Left lobe
T tube
60
40
2
No
8
Sgts VI-VII
Bilateral lobes & CBD
T tube
55
19
8
No
9
Bile duct confluence
Bilateral lobes
Open
25
27
3
No
10
Right hepatic duct
Sgts VI-VII
Open
30
14
1
No
11
Sgts II-III
Bilateral lobes
T tube
65
36
6
No
12
Sgt VI
Sgt VI
Open
35
44
1
No
13
Sgt VII
Right lobe
T-tube
35
33
2
No
14
Sgts II-III
Sgts II-III
Open
40
19
1
No
15
Sgts VI-VII
Right lobe
T tube
50
25
2
No
CBD common bile duct, Sgt segment
All patients were then followed up for 48 ± 12 months (mean ± s.d.; median 47, range 20–68) to obtain the long-term outcome data (Table 3). Four patients had hepatolithiasis recurrence during follow-up. A 63-year-old male had a rapid stricture recurrence with multiple stones at the left lateral lobe after 3 months post initial intervention, and underwent open left lateral hepatectomy, but unfortunately developed pancreatic cancer at 36 months post stone clearance. Another 3 patients had hepatolithiasis recurrence at 23, 26, and 36 months post stone clearance, and all chose to receive conservative therapy other than surgical treatment. The other patients did not report any postoperative recurrence of hepatolithiasis or biliary stricture after stone clearance during the follow-up period, resulting in a recurrence-free rate of 73% at 2 years and 67% at 5 years (Fig. 2). Two patients did not have hepatolithiasis recurrence but suffered from severe cirrhosis and pancreatitis, respectively. The patient with severe cirrhosis had a background of secondary biliary cirrhosis due to long-term of bile duct stricture at the procedure, and passed away due to variceal bleeding at 20 months post stone clearance. No other patient mortality was observed, indicating a 5-year overall survival rate of 93% (Fig. 2).
Table 3
Long-term outcomes post laser ablation of biliary stricture
Case #
Follow-up duration (months)
Recurrence of hepatolithiasis (time post stone clearance)
Recurrence of biliary stricture (time post stone clearance)
Other long-term outcomes (time post stone clearance)
Overall survival (months)
Recurrence-free survival (months)
1
47
Yes, multiple stones at left lateral lobe (3 months)
Yes (3 months)
Pancreatic cancer (36 months)
47
3
2
42
No
No
No
42
42
3
67
No
No
No
67
67
4
48
Yes, multiple stones at right lobe and CBD (26 months)
No
No
48
26
5
49
No
No
No
49
49
6
57
No
No
No
57
57
7
46
No
No
No
45
45
8
68
No
No
No
68
68
9
40
No
No
No
40
40
10
47
No
No
No
47
47
11
20
No
No
Cirrhosis-associated death (20 months)
20
20
12
55
No
No
Pancreatitis (30 months)
55
55
13
39
Yes, multiple CBD stones (23 months)
No
No
39
23
14
46
No
No
No
45
45
15
48
Yes, multiple CBD stones (36 months)
No
No
48
36
CBD common bile duct

Discussions

In this study we presented a novel method of hepatoliathiasis treatment to eliminate biliary stricture by Ho:YAG laser ablation during cholangioscopy. During the follow-up period of 717 person years, our study cohort demonstrated a superior recurrence-free rate, and 2/3 of the cohort individuals did not encounter stone recurrence. These results suggest that holmium laser ablation could be an effective approach for biliary stricture removal.
The holmium laser ablation is indicated in several clinical settings. The most common indication is biliary stricture with distal duct stones discovered during cholangioscopic exploration. Inappropriate managements, such as leaving the stricture intact, would results in residual hepatolithiasis stones in distal biliary duct and rapid recurrence of newly formed stones, even if the proximal duct stones had been clear. An alternative approach is surgical resection of the liver with biliary stricture, but it may cause significant blood loss and severe postoperative complications, especially in the patients with complicated biliary surgery history. Another indication of the laser ablation is biliary duct recanalization from the distal end in percutaneous transhepatic cholangioscopy (PTCS), to restore natural biliary drainage intrahepatically and to reduce future recurrence. Untreated biliary strictures during transhepatic cholangioscopy would block the cholangioscope from further inspection of the common bile duct, and could eventually induce stone recurrence due to impaired biliary patency. Therefore, the holmium laser ablation, due to its advantage of minimal invasiveness, is now the first choice for recurrent biliary stricture in our hospitals, after the initial surgical treatments lead to massive adherence and fast recurrence.
Holmium laser delivers pulsatile high energy to fragment bilious stones, which could easily cut the stricture tissue [21, 22]. Based on our experience, some membrane-like biliary strictures could be easily managed with a single and short episode of holmium laser ablation, and the stricture will spontaneously relieve itself by biliary ductal flexibility. Other kinds of adherence biliary strictures require a longer working episode of holmium laser and a spiral maneuver to be completely eliminated.
Meanwhile, the prolonged working episode of holmium ablation might raise the concern of excessive injury and biliary hemorrhage. In a few cases, mild biliary hemorrhage could be well controlled by a further holmium laser hemostatsis at the same beaming frequency and energy as ablation. However, we have not encountered any case of uncontrolled active biliary bleeding yet. In our previous experience of other biliary surgery cases, temporarily blocking the entry route of cholangioscopy to increase the intraluminal pressure of intrahepatic biliary duct may help to stop uncontrolled biliary bleeding. Within the reach of cholangioscopy, biliary hemorrhage could also be managed by using biliary stent to create focal pressure on the bleeding site [23]. The crisis of uncontrolled biliary hemorrhage could at last be managed with interventional radiology or emergency open laparotomy as well.
Comparing to other techniques previously reported [1520], the holmium laser ablation approach for biliary stricture shows several advantages. Firstly, the holmium laser ablation achieved a lower recurrence rate, which might benefit from more precise targeting, easier dilation, fewer scar formation, and less foreign substance retention in the biliary duct. Secondly, the holmium laser is originally designated for lithotripsy, and could be directly used for stricture ablation, therefore saving the surgeons’ time to change to new devices usually requiring additional learning. Finally, the shared device with lithotripsy also reduces the surgical cost on medical device, making the holmium laser ablation the most cost-effect approach among other techniques. Notably, the holmium laser ablation could be performed in combination with balloon dilation to accomplish better effect to relieve biliary stricture.
Our study also had several limitations. The first limitation is due to the study population, which had a small size and only included Chinese adult patients. The technique will be verified in a larger number of patients in the future, with homogeneous subgroups classified according to etiology, location, and number of the biliary stenosis. The second limitation is the follow-up duration, which is proper to evaluate the stone recurrence rate, but relatively short to allow better evaluation of late complications.

Conclusions

In conclusion, we developed a novel technique of biliary stricture removal by cholangioscopic holmium laser ablation with satisfying clinical outcomes. The stricture removal allows for cholangioscopic lithotripsy in more endoscopic settings such as distal-to-proximal PTCS approach, broadening the minimally invasive applications of endoscopic interventions against hepatolithiasis. Since hepatolithiasis manifests as a chronic disease, future research should be focused on technique upgrades to persistently prevent stricture formation and to efficiently reduce hepatolithiasis recurrence during the long follow-up period.

Acknowledgements

The authors thank Mr. Jianfeng Wang for his assistance in recording cholangioscopy videos and Dr. Wenyue Wu of Harvard University for language polishing. The authors also thank the multidisciplinary treatment group of hepatobiliary and pancreatic diseases of the Second Affiliated Hospital, Zhejiang University School of Medicine for their helpful advice in patient management.
This study was performed in accordance with the Declaration of Helsinki and human experimentation ethically approved by the institutional review board of the Second Affiliated Hospital, Zhejiang University School of Medicine (approval number 2012–355). The committee is constituted in accordance with the Governance arrangements for research ethics and complies fully with standard operating procedures for research committees in China. All subjects were over the age of 18 and gave written informed consent to receive the procedure described in this study.
Written informed consent was obtained from the patients for publication of this work and any accompanying images. A copy of the written consents is available for review by the Editor of this journal.

Competing interests

The authors declare that they have no competing interests.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Su CH, Lui WY, P’Eng FK. Relative prevalence of gallstone diseases in Taiwan. A nationwide cooperative study. Dig Dis Sci. 1992;37:764–8.CrossRef Su CH, Lui WY, P’Eng FK. Relative prevalence of gallstone diseases in Taiwan. A nationwide cooperative study. Dig Dis Sci. 1992;37:764–8.CrossRef
2.
Zurück zum Zitat Kim MH, Lim BC, Myung SJ, Lee SK, Ohrr HC, Kim YT, et al. Epidemiological study on Korean gallstone disease: a nationwide cooperative study. Dig Dis Sci. 1999;44:1674–83.CrossRef Kim MH, Lim BC, Myung SJ, Lee SK, Ohrr HC, Kim YT, et al. Epidemiological study on Korean gallstone disease: a nationwide cooperative study. Dig Dis Sci. 1999;44:1674–83.CrossRef
3.
Zurück zum Zitat Park YH, Park SJ, Jang JY, Ahn YJ, Park YC, Yoon YB, et al. Changing patterns of gallstone disease in Korea. World J Surg. 2004;28:206–10.CrossRef Park YH, Park SJ, Jang JY, Ahn YJ, Park YC, Yoon YB, et al. Changing patterns of gallstone disease in Korea. World J Surg. 2004;28:206–10.CrossRef
4.
Zurück zum Zitat Tazuma S. Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol. 2006;20:1075–83.CrossRef Tazuma S. Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol. 2006;20:1075–83.CrossRef
5.
Zurück zum Zitat Liang T, Su W, Zhang Q, Li G, Gao S, Lou J, et al. Roles of sphincter of Oddi laxity in bile duct microenvironment in patients with Cholangiolithiasis: from the perspective of the microbiome and Metabolome. J Am Coll Surg. 2016;222:269–80 e10.CrossRef Liang T, Su W, Zhang Q, Li G, Gao S, Lou J, et al. Roles of sphincter of Oddi laxity in bile duct microenvironment in patients with Cholangiolithiasis: from the perspective of the microbiome and Metabolome. J Am Coll Surg. 2016;222:269–80 e10.CrossRef
6.
Zurück zum Zitat Jeng KS, Sheen IS, Yang FS, Cheng SJ, Ohta I. Percutaneous transhepatic placement of metallic stents in the treatment of complicated intrahepatic biliary stricture with hepatolithiasis: a preliminary report. Am J Gastroenterol. 1999;94(12):3507–12.CrossRef Jeng KS, Sheen IS, Yang FS, Cheng SJ, Ohta I. Percutaneous transhepatic placement of metallic stents in the treatment of complicated intrahepatic biliary stricture with hepatolithiasis: a preliminary report. Am J Gastroenterol. 1999;94(12):3507–12.CrossRef
7.
Zurück zum Zitat He X, Liu Q. Diagnosis and treatment of hepatolithiasis (in Chinese). Chin J Dig Surg. 2015;14:275–9. He X, Liu Q. Diagnosis and treatment of hepatolithiasis (in Chinese). Chin J Dig Surg. 2015;14:275–9.
8.
Zurück zum Zitat Li SQ, Liang LJ, Peng BG, Hua YP, Lv MD, Fu SJ, et al. Outcomes of liver resection for intrahepatic stones: a comparative study of unilateral versus bilateral disease. Ann Surg. 2012;255:946–53.CrossRef Li SQ, Liang LJ, Peng BG, Hua YP, Lv MD, Fu SJ, et al. Outcomes of liver resection for intrahepatic stones: a comparative study of unilateral versus bilateral disease. Ann Surg. 2012;255:946–53.CrossRef
9.
Zurück zum Zitat Chen DW, Tung-Ping Poon R, Liu CL, Fan ST, Wong J. Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery. 2004;135:386–93.CrossRef Chen DW, Tung-Ping Poon R, Liu CL, Fan ST, Wong J. Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery. 2004;135:386–93.CrossRef
10.
Zurück zum Zitat Suzuki Y, Mori T, Abe N, Sugiyama M, Atomi Y. Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese multicenter study. Hepatol Res. 2012;42:166–70.CrossRef Suzuki Y, Mori T, Abe N, Sugiyama M, Atomi Y. Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese multicenter study. Hepatol Res. 2012;42:166–70.CrossRef
11.
Zurück zum Zitat Huang MH, Chen CH, Yang JC, Yang CC, Yeh YH, Chou DA, et al. Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis. Am J Gastroenterol. 2003;98:2655–62.CrossRef Huang MH, Chen CH, Yang JC, Yang CC, Yeh YH, Chou DA, et al. Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis. Am J Gastroenterol. 2003;98:2655–62.CrossRef
12.
Zurück zum Zitat Yoshida J, Chijiiwa K, Shimizu S, Sato H, Tanaka M. Hepatolithiasis: outcome of cholangioscopic lithotomy and dilation of bile duct stricture. Surgery. 1998;123:421–6.CrossRef Yoshida J, Chijiiwa K, Shimizu S, Sato H, Tanaka M. Hepatolithiasis: outcome of cholangioscopic lithotomy and dilation of bile duct stricture. Surgery. 1998;123:421–6.CrossRef
13.
Zurück zum Zitat Yoshimoto H, Ikeda S, Tanaka M, Matsumoto S, Kuroda Y. Choledochoscopic electrohydraulic lithotripsy and lithotomy for stones in the common bile duct, intrahepatic ducts, and gallbladder. Ann Surg. 1989;210:576–82.CrossRef Yoshimoto H, Ikeda S, Tanaka M, Matsumoto S, Kuroda Y. Choledochoscopic electrohydraulic lithotripsy and lithotomy for stones in the common bile duct, intrahepatic ducts, and gallbladder. Ann Surg. 1989;210:576–82.CrossRef
14.
Zurück zum Zitat Chen C, Huang M, Yang J, Yang C, Yeh Y, Wu H, et al. Reappraisal of percutaneous transhepatic cholangioscopic lithotomy for primary hepatolithiasis. Surg Endosc. 2005;19:505–9.CrossRef Chen C, Huang M, Yang J, Yang C, Yeh Y, Wu H, et al. Reappraisal of percutaneous transhepatic cholangioscopic lithotomy for primary hepatolithiasis. Surg Endosc. 2005;19:505–9.CrossRef
15.
Zurück zum Zitat Jeng KS, Yang FS, Chiang HJ, Ohta I. Bile duct stents in the management of hepatolithiasis with long-segment intrahepatic biliary strictures. Br J Surg. 1992;79:663–6.CrossRef Jeng KS, Yang FS, Chiang HJ, Ohta I. Bile duct stents in the management of hepatolithiasis with long-segment intrahepatic biliary strictures. Br J Surg. 1992;79:663–6.CrossRef
16.
Zurück zum Zitat Larghi A, Rimbas M, Attili F, Kunda R. Endoscopic holmium laser lithotripsy of symptomatic gallstones through a lumen-apposing self-expandable metal stent. Am J Gastroenterol. 2016;111:1516.CrossRef Larghi A, Rimbas M, Attili F, Kunda R. Endoscopic holmium laser lithotripsy of symptomatic gallstones through a lumen-apposing self-expandable metal stent. Am J Gastroenterol. 2016;111:1516.CrossRef
17.
Zurück zum Zitat Schoonjans R, De Man M, Aerts P, Van der Spek P, Van Steenberge R, Lepoutre L. Combined percutaneous balloon dilation and extracorporeal shock wave lithotripsy for treatment of biliary stricture and common bile duct stones. Am J Gastroenterol. 1994;89:1573–6.PubMed Schoonjans R, De Man M, Aerts P, Van der Spek P, Van Steenberge R, Lepoutre L. Combined percutaneous balloon dilation and extracorporeal shock wave lithotripsy for treatment of biliary stricture and common bile duct stones. Am J Gastroenterol. 1994;89:1573–6.PubMed
18.
Zurück zum Zitat Freeman ML, Cass OW, Dailey J. Dilation of high-grade pancreatic and biliary ductal strictures with small-caliber angioplasty balloons. Gastrointest Endosc. 2001;54:89–92.CrossRef Freeman ML, Cass OW, Dailey J. Dilation of high-grade pancreatic and biliary ductal strictures with small-caliber angioplasty balloons. Gastrointest Endosc. 2001;54:89–92.CrossRef
19.
Zurück zum Zitat Ogura T, Onda S, Sano T, Takagi W, Okuda A, Miyano A, et al. Evaluation of the safety of endoscopic radiofrequency ablation for malignant biliary stricture using a digital peroral cholangioscope (with videos). Dig Endosc. 2017;29:712–7.CrossRef Ogura T, Onda S, Sano T, Takagi W, Okuda A, Miyano A, et al. Evaluation of the safety of endoscopic radiofrequency ablation for malignant biliary stricture using a digital peroral cholangioscope (with videos). Dig Endosc. 2017;29:712–7.CrossRef
20.
Zurück zum Zitat Nakahara K, Michikawa Y, Morita R, Suetani K, Morita N, Sato J, et al. Diagnostic ability of endoscopic bile cytology using a newly designed biliary scraper for biliary strictures. Dig Dis Sci. 2019;64:241–8.CrossRef Nakahara K, Michikawa Y, Morita R, Suetani K, Morita N, Sato J, et al. Diagnostic ability of endoscopic bile cytology using a newly designed biliary scraper for biliary strictures. Dig Dis Sci. 2019;64:241–8.CrossRef
21.
Zurück zum Zitat Tarman GJ, Lenert JT, Hall L, Kane CJ. Holmium:YAG laser lithotripsy of intrahepatic biliary calculi. J Endourol. 1999;13:381–3.CrossRef Tarman GJ, Lenert JT, Hall L, Kane CJ. Holmium:YAG laser lithotripsy of intrahepatic biliary calculi. J Endourol. 1999;13:381–3.CrossRef
22.
Zurück zum Zitat Nakagawa A, Hirano T, Jokura H, Uenohara H, Ohki T, Hashimoto T, et al. Pulsed holmium:yttrium-aluminum-garnet laser-induced liquid jet as a novel dissection device in neuroendoscopic surgery. J Neurosurg. 2004;101:145–50.CrossRef Nakagawa A, Hirano T, Jokura H, Uenohara H, Ohki T, Hashimoto T, et al. Pulsed holmium:yttrium-aluminum-garnet laser-induced liquid jet as a novel dissection device in neuroendoscopic surgery. J Neurosurg. 2004;101:145–50.CrossRef
23.
Zurück zum Zitat Shinjo K, Matsubayashi H, Matsui T, Kawata N, Uemura S, Yamamoto Y, et al. Biliary hemostasis using an endoscopic plastic stent placement for uncontrolled hemobilia caused by transpapillary forceps biopsy (with video). Clin J Gastroenterol. 2016;9:86–8.CrossRef Shinjo K, Matsubayashi H, Matsui T, Kawata N, Uemura S, Yamamoto Y, et al. Biliary hemostasis using an endoscopic plastic stent placement for uncontrolled hemobilia caused by transpapillary forceps biopsy (with video). Clin J Gastroenterol. 2016;9:86–8.CrossRef
Metadaten
Titel
A novel approach with holmium laser ablation for endoscopic management of intrahepatic biliary stricture
verfasst von
Jianying Lou
Qida Hu
Tao Ma
Wei Chen
Ji Wang
Prasoon Pankaj
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2019
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-1093-y

Weitere Artikel der Ausgabe 1/2019

BMC Gastroenterology 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.